IGF1R and rhabdomyosarcoma: In rhabdomyosarcoma cell line Rh36, which is resistant to BMS-536924 (a small molecule inhibitor of IGF1R), combined analysis of targeting EGFR and IGFIR pathways revealed enhanced inhibitory activities [29].